Vimeo
LinkedIn
Instagram
Share |

Wealth

Grosvenor Group seeks ESG commercial property deals beyond London, Samsung’s ‘crown prince’ Lee Jae-yong released on parole, Warren Buffett maintains Berkshire Hathaway buyback spree over deals.

Grosvenor Group seeks ESG commercial property deals beyond London, Samsung’s ‘crown prince’ Lee Jae-yong released on parole, Warren Buffett maintains Berkshire Hathaway buyback spree over deals.

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

Molly Heaney, a fifth-generation director of JM Huber, one of the largest privately-owned businesses in the United States, says her family’s set of guiding principles remain the corporation’s “North Star” in its accelerating pace of investments.

Molly Heaney, a fifth-generation director of JM Huber, one of the largest privately-owned businesses in the United States, says her family’s set of guiding principles remain the corporation’s “North Star” in its accelerating pace of investments.

Bernhard Gademann says his family’s elite Swiss private boarding school, Institut auf dem Rosenberg, is run like a 132-year-old startup, with the skills and attitudes of entrepreneurialism nurtured in students in a state-of-the-art, holistic learning environment.

Bernhard Gademann says his family’s elite Swiss private boarding school, Institut auf dem Rosenberg, is run like a 132-year-old startup, with the skills and attitudes of entrepreneurialism nurtured in students in a state-of-the-art, holistic learning environment.

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

Click here >>
Close